-
Published20/12/2024
-
Deadline31/12/2024
-
Awarded11/03/2025
-
Today16/07/2025
Utilities
IRINOTECAN IV
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
MarchĆ© de fourniture dāirinotĆ©can 40mg, 100mg, 300 mg et 500mg en solution pour perfusion par voie intraveineuse.
https://www.publicprocurement.be/supplier/enterprises/0/tendering-workspaces/publication-workspace-detail/6cb8fb55-ee3c-4e24-8208-d099c15ee91c/general
https://www.publicprocurement.be/supplier/enterprises/0/tendering-workspaces/publication-workspace-detail/6cb8fb55-ee3c-4e24-8208-d099c15ee91c/general
Type: price
Description: Prix net total 73 points
Weight (percentage, exact):
Criterion:
Type: quality
Description: Approvisionnement et logistique 10 points QualitƩ 17 points
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.